Intermap Announces Appointment of New Director
CNW Group - Mon Apr 14, 1:11PM CDT
Intermap Technologies (TSX: IMP) (ITMSF: BB), a leading provider of geospatial solutions on-demand created from its uniform, high-resolution 3D digital models of the earth's surface, today announced the appointment of David Sikes to its Board of Directors effective April 9, 2014.
Intermap Technologies Reports 2013 Fourth Quarter and Year-End Financial Results
CNW Group - Mon Mar 17, 3:00PM CDT
(TSX: IMP) - Intermap Technologies Corporation ("Intermap" or the "Company"
Intermap Technologies 2013 Fourth Quarter Conference Call Notice
CNW Group - Thu Feb 27, 8:10AM CST
(TSX: IMP) - Intermap Technologies Corporation issued notice today that it will release its 2013 fourth quarter financial results following the close of markets on Monday, March 17, 2014.
Proformative Announces Winners of Inaugural ProformaTECH 2014 Awards for Excellence
PR Newswire - Thu Feb 13, 10:00AM CST
Proformative, the pioneering leader in Enterprise Social Procurement(TM) for the office of the CFO, today announced the winners of the company's first annual ProformaTECH 2014 Awards for Excellence, designed to honor visionary CFOs and their teams who have fully embraced technology as a vehicle for driving breakthrough performance. Winners in three categories will be recognized during the closing presentation of ProformaTECH 2014--the premier technology conference for senior corporate finance-related executives--which is being held today at the Venetian Las Vegas.
Intermap Completes US$5.0 Million Convertible Debt Financing
CNW Group - Fri Feb 07, 3:00PM CST
(TSX: IMP) - Intermap Technologies Corporation ("Intermap" or the "Company"
CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Phase 2 Trial Evaluating Pacritinib for Patients with Relapsed FLT3 Positive Acute Myeloid Leukemia
PR Newswire - Thu Jan 30, 12:30AM CST
Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis. Pacritinib is an oral JAK2/FLT3 inhibitor that has demonstrated encouraging activity in preclinical models of AML with mutated FLT3 gene, including additional FLT3 mutations that confer resistance to other targeted FLT3 agents. The trial is being conducted by the AML Working Group of the National Cancer Research Institute Haematological Oncology Study Group in Acute Myeloid Leukemia (AML) and high risk Myelodysplastic Syndrome (MDS) under the sponsorship of Cardiff University and supported by Cancer Research UK. The trial management group is lead by Professor Alan K. Burnett, Head of Haematology in the Department of Medical Genetics, Haematology and Pathology at the School of Medicine at Cardiff University.
Iberdrola S.A. Awarded 300 MW Combined-Cycle Power Plant Project in Baja California, Mexico
PR Newswire - Fri Jan 24, 6:10AM CST
Iberdrola USA parent company, Iberdrola S.A. has been awarded a contract for the construction and operation of the 300 megawatt (MW) Baja California III combined-cycle power plant in Mexico. Work on the $270 million plant and associated facilities will begin in April 2014 with commercial operation planned for August 2016.
Intermap Technologies Announces US$5.0 Million Convertible Debt Financing
CNW Group - Fri Jan 24, 4:30AM CST
Expansion capital accelerates the development and market introduction of Intermap's RiskProTM and GeoProTM 3D Business Intelligence software products
Intermap's NEXTMap® World 30(TM) Sales Surpass $1 Million on Demand Growth in 2013
CNW Group - Fri Jan 10, 7:45AM CST
- World 30 Sales Year-Over-Year Grow Over 15 Times in 2013 -
Intermap's NEXTMap® World 30™ Sales Surpass $1 Million on Demand Growth in 2013
PR Newswire - Fri Jan 10, 7:45AM CST
World 30 Sales Year-Over-Year Grow Over 15 Times in 2013 -
USD Outlook Weighed by Disinflation- JPY Unphased by BoJ
David Song, Currency Analyst - DailyFX - Fri Dec 20, 1:03PM CST
Talking Points:
Intermap Technologies Corporation to Present at the LD Micro Conference
PR Newswire - Mon Nov 25, 8:05AM CST
Intermap Technologies (IMP.TO), (ITMSF:BB), a leading provider of geospatial solutions on-demand created from its uniform, high-resolution 3D digital models of the earth's surface, today announced that Todd Oseth, president and CEO, and Richard Mohr, CFO, will present at the LD Micro Conference held December 3-5, 2013 at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Intermap Technologies Corporation will present on December 3rd at 8:30 AM, Pacific Time, track 4.
Intermap Technologies Reports 2013 Third Quarter Financial Results
CNW Group - Mon Nov 11, 3:00PM CST
(TSX: IMP) - Intermap Technologies Corporation ("Intermap" or the "Company"
Intermap Technologies 2013 Third Quarter Conference Call Notice
CNW Group - Wed Oct 30, 12:08PM CDT
(TSX: IMP) - Intermap Technologies Corporation issued notice today that it will release its 2013 third quarter financial results following the close of markets on Monday, November 11, 2013.
Intermap Completes Conversion of Convertible Note
CNW Group - Fri Aug 30, 5:20AM CDT
Intermap (TSX: IMP), (ITMSF:BB), a leading provider of geospatial solutions on-demand created from its uniform, high-resolution 3D digital models of the earth's surface, today announced that the Company has completed the second and final tranche of the conversion into common shares ("Common Shares"
Intermap Delivers Increased Value with NEXTMap® World 30™ v2.0
PR Newswire - Wed Aug 21, 5:05AM CDT
Elevation Data Integrates Seamlessly with Intermap's Orion Platform™ -